CAS:224785-91-5
MF: C23H33ClN6O4S
It also is rapidly absorbed and peaks in concentration (9.05 μg/mL after a 10-mg dose) after 0.9 hours, displaying a half-life of 4 to 5 hours. The absorption rate of it are reduced when taken with a high-fat diet. The drug also is metabolized by hepatic CYP3A4, and a potential for drug–drug interaction with inhibitors or enhancers of CYP3A4 exists.
- Description
- Additional information
Description
CAS 224785-91-5 Product Information
Product Name: | CAS 224785-91-5 |
Synonyms: | 1-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-piperazine dihydrochloride;2-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one hydrochloride;var hydrochloride; Var Hydrochloride Trihydrate 224785-90-4 /;Levitra,Valdenafil.HCl;1-[[3-(1,4-Dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-piperazine;Nuviva;VAR LMONOHYDROCHLORIDE(SUBJECTTOPATENTFREE) |
CAS NO: | 224785-91-5 |
Molecular Weight: | 525.07 |
Molecular Formula: | C23H33ClN6O4S |
Boiling Point: | 692.2ºC at 760 mmHg |
Melting point: | 214-216°Curology |
Density: | 1.0±0.1 g/cm3 |
Appearance: | White to Off-White Cyrstalline Solid |
Applications: | It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency. It should be noted that testosterone undecanoate is only indicated for treatment of hypogonadal conditions with structural or genetic etiologies and should not be used to manage “age-related hypogonadism”. |
Solubility: | DMSO : 10 mg/mL (21.90 mM; Need ultrasonic and warming) |
Storage: | Controlled Substance, -20°C Freezer |
Additional information
Color | White |
---|---|
Form | Powder |
Reviews
There are no reviews yet.